Partnership advances biotech business development involving the University of Alabama and Apimeds Pharmaceuticals.
2 reports, 1 independent
Updated Aug 26
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Partnership advances biotech business development involving the University of Alabama and Apimeds Pharmaceuticals.
Who's involved
What this event is mainly aboutUniversity of AlabamaBrian Peters
How it developed
Newest first. Tap a step to see who reported it.Brian Peters serves as SVP of ai² in a biotech partnership with the University of Alabama.1 source
Apimeds appoints Erik Emerson as CEO and Brian Peters as Head of ai² division.1 source
Keep exploring
The entities involved
-
University of Alabama
public university located in Tuscaloosa, Alabama, United States
Coverage
Newest first; wire copies grouped- Business WireApimeds Pharmaceuticals US, Inc. Partners with University of Alabama to Advance Biotech Business Development via ai² Future Labs MATAWAN, N.J., August 25, 2025--(BUSINESS WIRE)--Apimeds Pharmaceutica
- Business WireApimeds Expands Leadership Team with Dr. Susan Kramer to Lead Product Development and Brian Peters to Lead its ai² Division MATAWAN, N.J., July 15, 2025--(BUSINESS WIRE)--Apimeds Pharmaceuticals US,